Health Discovery Corp (HDVY)

[Degreed]

Another notch in the belt the potential and future earning are as obvious as day and night here.


HDVY (.075) Announces Grant of New Japanese Patent and Acceptance of Australian Patent Application Covering HDC'S SVM-Based Image Analysis Technology
Aug 22, 2007 12:25:00 PM
Copyright Business Wire 2007

SAVANNAH, Ga.--(BUSINESS WIRE)--

Health Discovery Corporation (HDC) (OTCBB:HDVY) today announced that the Japanese Patent Office has granted Patent No. 3,947,109 on HDC's claims covering the use of SVMs in computer-aided image analysis. The application of SVMs to image analysis has important implications in a wide range of technologies, including medical applications, such as x-ray interpretation, digital mammography and circulating tumor cell evaluation, security and law enforcement uses, such as face, fingerprint, and handwriting recognition, and defense applications, such as satellite image analysis, among other applications. The covered methods use a dedicated SVM subsystem to classify each different characteristic or feature of interest within a digitized image. After successful classification of the individual features within the different subsystems, another SVM evaluates the results from the combined subsystems to generate a conclusion based on all relevant data in the image.

Health Discovery Corporation also this week received a Notice of Acceptance from IP Australia, the Australian patent office, of the Australian counterpart of the newly granted Japanese patent. Both the Japanese patent and the Australian application correspond to HDC's previously issued U.S. Patent No. 6.996,549, along with additional pending U.S. and foreign patent applications covering its SVM image analysis technology.

Once the Australian SVM image analysis patent is granted, Health Discovery Corporation will hold the exclusive rights to 28 issued U.S. and foreign patents covering uses of SVM and FGM (fractal genomics modeling) technology for discovery of knowledge from large data sets. Other issued patents cover methods and systems for pre-processing of data to enhance knowledge discovery using SVMs, analysis of data using multiple support vector machines and for multiple data sets, and providing SVM analysis services over the Internet. HDC's pending U.S. and foreign patent applications cover numerous improvements to and applications of SVMs including computer-aided image analysis using SVMs, with particular application to diagnosis using medical images, methods of feature selection for enhanced SVM efficiency and biomarkers for colon cancer, prostate cancer, BPH and renal cancer discovered with these methods, and use of SVMs for analysis of spectral data, such as mass spectrometry data used for protein analysis.

"These newly issued SVM based image analysis patents will add significant value to the international expansion and protection of HDC's patent estate," said Stephen D. Barnhill, M.D., HDC's Chairman and Chief Executive Officer. "These two new patent issuances have particular importance given the steady increase in demand for medical imaging services in the worldwide radiology and digital pathology market. As one example, the market for image analysis based interpretation of mammography is expected to continue its rapid growth based on the availability of computer assisted detection (CAD) which has fueled demand for more accurate early-detection screening programs for breast cancer. This international expansion of HDC's intellectual property portfolio for image analysis creates an excellent opportunity for the company to provide more expansive patent protection to our potential development partners currently operating in the global markets for digital radiology and digital pathology, as well as, increasing protected market expansion into these important additional countries."

Savannah-based Health Discovery Corporation (OTCBB:HDVY) is uniquely positioned in the field of pattern recognition technology. Through the application of its patent protected technology, HDC is a biology-oriented biomarker discovery company providing all aspects of First-Phase Biomarker Discovery(sm). The Company's SVM and FGM pattern recognition tools have significant application potential in other sizable commercial markets such as radiology, financial markets, Internet search and spam, homeland security, and other areas where analysis of large volumes of complex data is required.

Source: Health Discovery Corporation

----------------------------------------------

Health Discovery Corporation
Daniel R. Furth
912-443-1987
[e-mail]
www.healthdiscoverycorp.com